Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has been found to cause multiple complications …

Objective: Unusual clinical course Background: Coagulation abnormalities are frequently
encountered in patients with coronavirus disease 2019 (COVID-19), especially in those with …

COVID-19 is caused by the SARS-CoV-2, and its presentation ranges from mild upper
respiratory illness to critical disease including acute respiratory distress syndrome and …

Severe coronavirus disease 2019 (COVID-19) as a respiratory tract infection has been noted
to be a causative agent for acute respiratory distress syndrome, shock, and multiple organ …

Coagulation abnormalities and thrombosis have been recently identified as sequelae of
severe infection with the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV …

Objective: Unusual clinical course Background: Severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) is the viral pathogen responsible for coronavirus disease 2019 …

Severe acute respiratory syndrome coronavirus 2, coronavirus disease 2019 (COVID-19)-
induced infection can be associated with a coagulopathy, findings consistent with infection …

Recently, literature recognized an association between coronavirus disease-19 (COVID-19)
and coagulopathy [1]. COVID-19 illness severity is positively correlated with coagulopathy …

Background For more than a year, health systems all over the world have been combating
the global coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute …

A well-known complication of COVID-19 is hypercoagulability in both the venous and arterial
circulation. Most cases of hypercoagulability-related complications have been described in …